title: Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy.
abstract: Altered fat distribution is associated with insulin resistance in HIV, but little is known about regional glucose metabolism in fat and muscle depots in this patient population. The aim of the present study was to quantify regional fat, muscle, and whole body glucose disposal in HIV-infected men with lipoatrophy. Whole body glucose disposal was determined by hyperinsulinemic clamp technique (80 mU x m(-2) x min(-1)) in 6 HIV-infected men and 5 age/weight-matched healthy volunteers. Regional glucose uptake in muscle and subcutaneous (SAT) and visceral adipose tissue (VAT) was quantified in fasting and insulin-stimulated states using 2-deoxy-[18F]fluoro-D-glucose positron emission tomography. HIV-infected subjects with lipoatrophy had significantly increased glucose uptake into SAT (3.8 +/- 0.4 vs. 2.3 +/- 0.5 micromol x kg tissue(-1) x min(-1), P < 0.05) in the fasted state. Glucose uptake into VAT did not differ between groups. VAT area was inversely related with whole body glucose disposal, insulin sensitivity, and muscle glucose uptake during insulin stimulation. VAT area was highly predictive of whole body glucose disposal (r2 = 0.94, P < 0.0001). This may be mediated by adiponectin, which was significantly associated with VAT area (r = -0.75, P = 0.008), and whole body glucose disposal (r = 0.80, P = 0.003). This is the first study to directly demonstrate increased glucose uptake in subcutaneous fat of lipoatrophic patients, which may partially compensate for loss of SAT. Furthermore, we demonstrate a clear relationship between VAT and glucose metabolism in multiple fat and muscle depots, suggesting the critical importance of this depot in the regulation of glucose and highlighting the significant potential role of adiponectin in this process.
authors.affiliation: Program in Nutritional Metabolism, Massachusetts General Hospital, 55 Fruit St., LON 207, Boston, MA 02114, USA. chadigan@partners.org
authors.forename: C
authors.initials: C
authors.lastname: Hadigan
authors.forename: D
authors.initials: D
authors.lastname: Kamin
authors.forename: J
authors.initials: J
authors.lastname: Liebau
authors.forename: S
authors.initials: S
authors.lastname: Mazza
authors.forename: S
authors.initials: S
authors.lastname: Barrow
authors.forename: M
authors.initials: M
authors.lastname: Torriani
authors.forename: R
authors.initials: R
authors.lastname: Rubin
authors.forename: S
authors.initials: S
authors.lastname: Weise
authors.forename: A
authors.initials: A
authors.lastname: Fischman
authors.forename: S
authors.initials: S
authors.lastname: Grinspoon
mesh_terms: D000273:Adipose Tissue / Q000378:metabolism*; D000328:Adult; D005947:Glucose / Q000378:metabolism*; D039682:HIV-Associated Lipodystrophy Syndrome / Q000378:metabolism*; D006801:Humans; D007328:Insulin / Q000097:blood*; D007333:Insulin Resistance; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000378:metabolism*
chemical_list: D007328:Insulin; D005947:Glucose